- Home
- MMI vs CLDX Comparison
MMI vs CLDX Comparison
Compare MMI & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMI
- CLDX
- Stock Information
- Founded
- MMI 1971
- CLDX N/A
- Country
- MMI United States
- CLDX United States
- Employees
- MMI N/A
- CLDX N/A
- Industry
- MMI Real Estate
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MMI Finance
- CLDX Health Care
- Exchange
- MMI Nasdaq
- CLDX Nasdaq
- Market Cap
- MMI 1.2B
- CLDX 1.3B
- IPO Year
- MMI 2013
- CLDX 2008
- Fundamental
- Price
- MMI $31.90
- CLDX $21.73
- Analyst Decision
- MMI Sell
- CLDX Buy
- Analyst Count
- MMI 1
- CLDX 9
- Target Price
- MMI $30.00
- CLDX $50.00
- AVG Volume (30 Days)
- MMI 171.6K
- CLDX 1.2M
- Earning Date
- MMI 08-06-2025
- CLDX 08-07-2025
- Dividend Yield
- MMI 1.61%
- CLDX N/A
- EPS Growth
- MMI N/A
- CLDX N/A
- EPS
- MMI N/A
- CLDX N/A
- Revenue
- MMI $711,994,000.00
- CLDX $7,559,000.00
- Revenue This Year
- MMI $11.69
- CLDX N/A
- Revenue Next Year
- MMI $24.07
- CLDX N/A
- P/E Ratio
- MMI N/A
- CLDX N/A
- Revenue Growth
- MMI 14.79
- CLDX 24.49
- 52 Week Low
- MMI $27.61
- CLDX $14.40
- 52 Week High
- MMI $42.80
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- MMI 51.26
- CLDX 49.37
- Support Level
- MMI $30.19
- CLDX $19.52
- Resistance Level
- MMI $31.41
- CLDX $22.11
- Average True Range (ATR)
- MMI 0.89
- CLDX 1.33
- MACD
- MMI 0.03
- CLDX -0.07
- Stochastic Oscillator
- MMI 50.46
- CLDX 18.29
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.